netFormulary NHS
South Staffordshire Joint Formulary
Cannock Chase Clinical Commissioning Group
East Staffordshire Clinical Commissioning Group
South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group
Stafford and Surrounds Clinical Commissioning Group
 Search
 Formulary Chapter 4: Central nervous system - Full Chapter
04.07.01  Expand sub section  Non-opioid analgesics and compound analgesic preparations
04.07.01  Expand sub section  Compound analgesic preparations
Co-Codamol - 8/500mg
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Co-Codamol Tablet 8mg/500mg
Co-Codamol Effervescent Tablet 8mg/500mg

NOT an evidence based choice but patients may perceive benefit.
Please note over the counter (OTC) sale is limited to three days only.

 
   
Co-Codamol - 30/500mg
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Co-Codamol Capsule 30mg/500mg
Co-Codamol Tablet 30mg/500mg
Co-Codamol Effervescent Tablet 30mg/500mg

Prescribing as separate components allows dosing flexibility and is less expensive (Applicable to primary care only).

Ensure soluble forms are prescribed only if appropriate.

 
   
 ....
 Non Formulary Items
actipatch

View adult BNF View SPC online View childrens BNF Track Changes
Non Formulary

Pulsed electromagnetic stimulator patches

This has recently been made available on the NHS. locally the evidence needs to be reviewed before a decision can be made as to whether this is supported locally.

Currently it is non formulary.

 
Aspirin  (Caprin®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Aspirin  (Nu-Seals® Aspirin)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Aspirin and codeine  (Co-codaprin)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Aspirin and papaveretum  (Aspav)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Co-proxamol

View adult BNF View SPC online View childrens BNF Track Changes
Non Formulary

NHS England Guidance for CCGs4:

  • prescribers in primary care should not initiate co-proxamol for any new patient.
  • prescribers should be supported in deprescribing co-proxamol in all patients and, where appropriate, ensure the availability of relevant services to facilitate this change.

No routine exceptions have been identified.

Alternative analgesics e.g. paracetamol and codeine or co-codamol tablets.

 
Nefopam

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Nefopam  (Acupan)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Paracetamol  (Panadol OA®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Paracetamol  (Perfalgan)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Paracetamol and codeine  (Codipir)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Paracetamol and codeine  (Kapake)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Paracetamol and codeine  (Solpadol)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Paracetamol and codeine  (Tylex)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Paracetamol and dihydrocodeine  (Co-dydramol)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Paracetamol and dihydrocodeine  (Remedeine)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Paracetamol and methionine  (Pardote)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Drugs which require special consideration. These are drugs for Consultant Prescribing ONLY. They should not be prescribed in Primary Care.  

Amber

Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care. For some drugs there may be a Ricad in place to aid the transition to primary care.  

Amber E

Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care but also require and ESCA (Shared Care Agreement)   

Green

Suitable first-line drugs for implementation in Primary Care  

On Formulary

South Staffs Formulary Choice  

netFormulary